Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Other Non Operating Income: 2011-2024

Historic Other Non Operating Income for Catalyst Pharmaceuticals (CPRX) over the last 14 years, with Dec 2024 value amounting to $21.1 million.

  • Catalyst Pharmaceuticals' Other Non Operating Income fell 24.27% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.0 million, marking a year-over-year increase of 82.37%. This contributed to the annual value of $21.1 million for FY2024, which is 174.57% up from last year.
  • Catalyst Pharmaceuticals' Other Non Operating Income amounted to $21.1 million in FY2024, which was up 174.57% from $7.7 million recorded in FY2023.
  • Catalyst Pharmaceuticals' 5-year Other Non Operating Income high stood at $21.1 million for FY2024, and its period low was $282,000 during FY2021.
  • In the last 3 years, Catalyst Pharmaceuticals' Other Non Operating Income had a median value of $7.7 million in 2023 and averaged $10.6 million.
  • Per our database at Business Quant, Catalyst Pharmaceuticals' Other Non Operating Income tumbled by 62.99% in 2020 and then surged by 921.63% in 2022.
  • Catalyst Pharmaceuticals' Other Non Operating Income (Yearly) stood at $587,000 in 2020, then tumbled by 51.96% to $282,000 in 2021, then soared by 921.63% to $2.9 million in 2022, then spiked by 167.23% to $7.7 million in 2023, then spiked by 174.57% to $21.1 million in 2024.